Reports for CANDESARTAN CILEXETIL
Ingredient
CANDESARTAN CILEXETIL
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TARO-CANDESARTAN | 4MG | TABLET | Actual shortage | 2024-09-11 | 2025-01-28 | 237290 |
| TARO-CANDESARTAN | 8MG | TABLET | Resolved | 2021-01-31 | 2021-05-01 | 132929 |
| TARO-CANDESARTAN | 8MG | TABLET | Resolved | 2022-08-25 | 2022-11-03 | 167926 |
| TARO-CANDESARTAN | 8MG | TABLET | Actual shortage | 2023-11-02 | 2025-01-28 | 208955 |
| TARO-CANDESARTAN | 16MG | TABLET | Resolved | 2021-01-31 | 2021-02-14 | 132926 |
| TARO-CANDESARTAN | 16MG | TABLET | Resolved | 2022-08-25 | 2022-11-03 | 167929 |
| TARO-CANDESARTAN | 16MG | TABLET | Resolved | 2023-02-01 | 2023-09-25 | 183064 |
| TARO-CANDESARTAN | 16MG | TABLET | Resolved | 2023-11-02 | 2024-01-05 | 208958 |
| TARO-CANDESARTAN | 16MG | TABLET | Actual shortage | 2024-10-16 | 2025-01-28 | 240421 |
| TARO-CANDESARTAN | 32MG | TABLET | Resolved | 2022-08-25 | 2023-09-26 | 167932 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| CANDESARTAN | 4MG | TABLET | Discontinued | 2017-06-06 | 2017-06-07 | 12033 |
| MYLAN-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53628 |
| MYLAN-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53621 |
| MYLAN-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-07-03 | 2018-08-11 | 53616 |
| MYLAN-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-07-03 | 2018-07-04 | 53611 |